A chimeric antigen receptor uniquely recognizing MICA/B stress proteins provides an effective approach to target solid tumors
John Goulding(Fate Therapeutics (United States)), Bahram Valamehr(Fate Therapeutics (United States))
Cited by 25
Related Papers
Harnessing features of adaptive NK cells to generate iPSC-derived NK cells for enhanced immunotherapy
|Cell stem cell|2021|153
iPSC-derived natural killer cells expressing the FcγR fusion CD64/16A can be armed with antibodies for multitumor antigen targeting
|Journal for ImmunoTherapy of Cancer|2023|21